Let's explore several standout options from the results in the screener. Overview: Genomictree Inc. is a South Korean biomarker-based molecular diagnostics company that focuses on developing products ...

Since the 12·3 emergency martial law incident, volatility in the domestic stock market has increased, causing most stocks to fluctuate, while the corporate value of early cancer diagnosis company ...

Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company ...

Genomictree (KQ:228760) Annual Report This summary provides an overview of the most significant critical numbers from each of the Genomictree financial reports, including the Genomictree Inc income ...

Genomictree (228760) has delivered a 16% change over the past year, with a 52-week range between 11,390 and 29,150. What Is the Average Daily Trading Volume of Genomictree (228760)? The average daily ...

Genomictree (228760) Earnings Dates & Reports On this page, you can find detailed information about the financial performance of Genomictree Inc, including the latest Genomictree Inc earnings report ...

HONG KONG – South Korea’s Genomictree Co. Ltd. has said its U.S. branch, Promis Diagnostics Inc., based in Pasadena, Calif., gained $30.8 million in funds this month. The Daejeon-based company has ...

Genomictree Inc. OverviewBiotechnology / Healthcare Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Visit a quote page and your recently viewed tickers will be displayed here.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Genomictree, Inc. engages in the development and supply of diagnostic products for cancer screening and prognosis. Its products include equipment for detection of cancer, diagnostics, and other ...